New Market Study, "Caprion Inc. - Product Pipeline Analysis, 2014 Update", Has Been Published
Caprion Inc. (Caprion) is a provider of proteomics biomarker and target identification services. It offers services such as biomarker services, in-vitro diagnostics and drug targets. Caprion provides services for target discovery and clinical validation of biomarkers using its proteomics discovery platform CellCarta. Caprion's CellCarta is used in profiling proteins in solid tissues and plasma. It develops in-vitro diagnostic product candidates in the areas of infectious diseases, oncology and diabetes. It also provides bio analytical services, cell fractionation and sample procurement...
View full press release